BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Schneider-Hohendorf T, Gerdes LA, Pignolet B, et al. (2022) Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis. The Journal of Experimental Medicine. 219 |
| Fissolo N, Pignolet B, Rio J, et al. (2021) Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab. Neurology(R) Neuroimmunology & Neuroinflammation. 8 |
| Ostkamp P, Salmen A, Pignolet B, et al. (2021) Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Cohen M, Mondot L, Bucciarelli F, et al. (2020) BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520969145 |
| Albrecht P, Bjørnå IK, Brassat D, et al. (2018) Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting. Therapeutic Advances in Neurological Disorders. 11: 1756286418803248 |
| Bernard-Valnet R, Pignolet B, Biotti D, et al. (2018) Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab. Multiple Sclerosis and Related Disorders. 25: 216-218 |
| Fissolo N, Pignolet B, Matute-Blanch C, et al. (2017) MMP9 is decreased in natalizumab-treated MS patients at risk for PML. Annals of Neurology |
| Maillart E, Vidal JS, Brassat D, et al. (2017) Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome. Neurology(R) Neuroimmunology & Neuroinflammation. 4: e346 |
| Pivot D, Debouverie M, Grzebyk M, et al. (2016) Geographical Heterogeneity of Multiple Sclerosis Prevalence in France. Plos One. 11: e0167556 |
| Michel L, Foucher Y, Vukusic S, et al. (2012) Increased risk of multiple sclerosis relapse after in vitro fertilisation Journal of Neurology, Neurosurgery and Psychiatry. 83: 796-802 |